Professor Liana Tumasyan

Back

Professor Liana Tumasyan

Institute of Cardiology of Yerevan, Yerevan (Armenia)

Member of:

LIANA R. TUMASYAN, MD, PhD, Doctor of Science Research Institute of Cardiology, Department of Heart Failure 5 P. Sevak, 0004, Yerevan, Armenia Phone: +37491 205867, +37493205867 E-mail: lianatumasyan@gmail.com Date of birth 02/23/1967 PhD DISSERTATION “Left ventricular diastolic dysfunction in chronic heart failure and possibility of its medical correction (December 2000); Doctor of Science DISSERTATION “Dynamic of structural and functional parameters of heart chambers in the prediction and prevention of clinical outcomes in chronic heart failure during long-term pharmacotherapy” (June 2013) Total number of publications 1160, co-author of the monographs “Chronic Heart failure” (2001), “Stable coronary artery disease” (2015) and “Heart Failure (2017). Total number of presentations 77. Fellow of Heart Failure Association of European Society of Cardiology, Board Member of Armenian Cardiologists Association, Chair of Working Group of Heart Failure of Armenian Cardiologist Association.

Presentations

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Heart failure treatment, HFpEF, HFmrEF

Access

Comparative efficacy of renin-angiotensin aldesteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with mid-ranged and preserved ejection fraction

Event: Heart Failure 2019

Topic: Cardiovascular Pharmacotherapy, Other

Session: Pharmacology and Pharmacotherapy

Access

Comparative efficacy of long-term digoxin and ivabradine therapy on prognosis, left and right heart functional parameters in patients with chronic heart failure and mid-ranged ejection fraction

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access

Prognostic value of right and left heart functional parameters and levels of biomarkers in chronic heart failure patients with preserved, mid-ranged and reduced ejection fraction

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Comparative efficacy of renin-angiotensin system modulators on prognosis, right and left heart functional parameters in chronic heart failure in relation to mid-ranged or preserved ejection fraction

Event: Heart Failure 2018

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access

Efficacy of long-term ivabradine therapy in severe systolic chronic heart failure patients with and without type 2 diabetes mellitus

Event: EuroEcho-Imaging 2016

Topic: Dilated cardiomyopathy

Session: Cardiomyopathies

Access

Efficacy of long-term ivabradine therapy on prognosis, right heart and left atrial parameters in patients with severe systolic chronic heart failure

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Drug therapy, other

Access

Professor Liana Tumasyan

Biography

Contributor content

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Comparative efficacy of renin-angiotensin aldesteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with mid-ranged and preserved ejection fraction

Comparative efficacy of long-term digoxin and ivabradine therapy on prognosis, left and right heart functional parameters in patients with chronic heart failure and mid-ranged ejection fraction

Prognostic value of right and left heart functional parameters and levels of biomarkers in chronic heart failure patients with preserved, mid-ranged and reduced ejection fraction

Comparative efficacy of renin-angiotensin system modulators on prognosis, right and left heart functional parameters in chronic heart failure in relation to mid-ranged or preserved ejection fraction

Efficacy of long-term ivabradine therapy in severe systolic chronic heart failure patients with and without type 2 diabetes mellitus

Efficacy of long-term ivabradine therapy on prognosis, right heart and left atrial parameters in patients with severe systolic chronic heart failure

ESC 365 is supported by